medetomidine

Clinicians at Penn Medicine report a growing number of patients experiencing severe withdrawal symptoms linked to medetomidine, a sedative increasingly found in the illicit drug supply. Health experts warn the drug may be mixed with opioids like fentanyl, complicating treatment and making withdrawal harder to manage than typical opioid dependence.